Exodus Point Capital Management, LP Denali Therapeutics Inc. Transaction History

Exodus Point Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$20.63 - $30.17 $358,570 - $524,384	17,381 New	17,381 $359,000
Q1 2023 May 11, 2023	BUY	$21.91 - $32.67 $545,712 - $813,711	24,907 New	24,907 $574,000
Q3 2022 Nov 10, 2022	SELL	$25.97 - $38.53 $1.06 Million - $1.57 Million	-40,753 Reduced 63.49%	23,434 $719,000
Q2 2022 Aug 19, 2022	BUY	$20.88 - $35.19 $1.34 Million - $2.26 Million	64,187 New	64,187 $1.89 Million
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $1.02 Million - $1.64 Million	-20,959 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $1.05 Million - $1.64 Million	20,959 New	20,959 $1.64 Million
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $211,121 - $535,443	-5,723 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$23.13 - $38.84 $229,310 - $385,059	-9,914 Reduced 63.4%	5,723 $205,000
Q2 2020 Aug 14, 2020	BUY	$16.01 - $28.82 $250,348 - $450,658	15,637 New	15,637 $378,000
Q4 2019 Feb 14, 2020	SELL	$14.4 - $19.99 $144,000 - $199,899	-10,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.32 - $21.92 $153,200 - $219,200	10,000 New	10,000 $153,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $28.14 $254,745 - $387,487	-13,770 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.99 - $24.65 $247,722 - $339,430	13,770 New	13,770 $320,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.